← back to search

Asier Antoranz

VIB-KU Leuven Center for Cancer Biology · BE
🔎 Find collaborators in Immunology · Oncology →
Search 5.9M scientists by topic, h-index, country & funding — free.
Area of research
Immunology · Oncology
Research interest
Research interests include Cancer Immunotherapy and Biomarkers, Immunotherapy and Immune Responses, Single-cell and spatial transcriptomics, and Monoclonal and Polyclonal Antibodies Research.
h-index
24
citations
3,620
works
170
NIH funding
primary concept
Medicine
email

Recent publications

Cytotoxic NK Cells Impede Response to Checkpoint Immunotherapy in Melanoma with an Immune-Excluded Phenotype
Cancer Discovery 2025cited by 20position: middledoi
A TCF4-dependent gene regulatory network confers resistance to immunotherapy in melanoma
Cell 2024cited by 170position: middledoi
Nucleotide metabolism in cancer cells fuels a UDP-driven macrophage cross-talk, promoting immunosuppression and immunotherapy resistance
Nature Cancer 2024cited by 53position: middledoi
PI3K/mTOR inhibition induces tumour microenvironment remodelling and sensitises pS6<sup>high</sup> uterine leiomyosarcoma to PD‐1 blockade
Clinical and Translational Medicine 2024cited by 20position: middledoi
CD4+ T cell-induced inflammatory cell death controls immune-evasive tumours
Nature 2023cited by 285position: middledoi
Transcriptional and spatial profiling of the kidney allograft unravels a central role for FcyRIII+ innate immune cells in rejection
Nature Communications 2023cited by 116position: middledoi
Multiomics and spatial mapping characterizes human CD8 <sup>+</sup> T cell states in cancer
Science Translational Medicine 2023cited by 79position: middledoi
Cancer immunotherapies transition endothelial cells into HEVs that generate TCF1+ T lymphocyte niches through a feed-forward loop
Cancer Cell 2022cited by 147position: middledoi
Mapping the Immune Landscape in Metastatic Melanoma Reveals Localized Cell–Cell Interactions That Predict Immunotherapy Response
Cancer Research 2022cited by 61position: firstdoi
Next-Generation Pathology Using Multiplexed Immunohistochemistry: Mapping Tissue Architecture at Single-Cell Level
Frontiers in Oncology 2022cited by 46position: middledoi
Single-cell profiling of myeloid cells in glioblastoma across species and disease stage reveals macrophage competition and specialization
Nature Neuroscience 2021cited by 658position: middledoi
Monocyte-driven atypical cytokine storm and aberrant neutrophil activation as key mediators of COVID-19 disease severity
Nature Communications 2021cited by 260position: middledoi
Multiplexed Immunohistochemistry and Digital Pathology as the Foundation for Next-Generation Pathology in Melanoma: Methodological Comparison and Future Clinical Applications
Frontiers in Oncology 2021cited by 39position: middledoi
A fully defined matrix to support a pluripotent stem cell derived multi-cell-liver steatohepatitis and fibrosis model
Biomaterials 2021cited by 37position: middledoi
Anticancer immunotherapies transition postcapillary venules into high-endothelial venules that generate TCF1+ T lymphocyte niches through a feed-forward loop
bioRxiv (Cold Spring Harbor Laboratory) 2021cited by 1position: middledoi
A pan-cancer blueprint of the heterogeneous tumor microenvironment revealed by single-cell profiling
Cell Research 2020cited by 855position: middledoi
Functional heterogeneity of lymphocytic patterns in primary melanoma dissected through single-cell multiplexing
eLife 2020cited by 62position: middledoi
In-depth characterization of the tumor microenvironment in central nervous system lymphoma reveals implications for immune-checkpoint therapy
Cancer Immunology Immunotherapy 2020cited by 59position: middledoi
Computerised scoring protocol for identification and quantification of different immune cell populations in breast tumour regions by the use of QuPath software
Histopathology 2020cited by 46position: middledoi
Age‐related remodelling of the blood immunological portrait and the local tumor immune response in patients with luminal breast cancer
Clinical & Translational Immunology 2020cited by 38position: middledoi
A Functional Landscape of CKD Entities From Public Transcriptomic Data
Kidney International Reports 2019cited by 41position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Francesca M. Bosisio · VIB-KU Leuven Center for Cancer Biology11 papers (2020–2025)Yannick Van Herck · KU Leuven6 papers (2020–2025)Giuseppe Floris · Twitter (United States)5 papers (2020–2022)Oliver Bechter · Universitair Ziekenhuis Leuven4 papers (2020–2025)Ann Smeets · Universitair Ziekenhuis Leuven4 papers (2020–2022)Jean‐Christophe Marine · Cancer Research UK4 papers (2021–2025)Lukas Marcelis · Universitair Ziekenhuis Leuven4 papers (2020–2022)Giorgio Cattoretti · KU Leuven4 papers (2020–2022)Diether Lambrechts · Center for Human Genetics4 papers (2020–2025)Veerle Boecxstaens · KU Leuven3 papers (2020–2025)Frederik De Smet · VIB-KU Leuven Center for Cancer Biology3 papers (2021–2022)Maddalena M. Bolognesi · KU Leuven3 papers (2020–2022)Damya Laoui · Vrije Universiteit Brussel3 papers (2020–2022)David Nittner · VIB-KU Leuven Center for Cancer Biology2 papers (2021–2022)Matthias Van Haele · KU Leuven2 papers (2021–2022)Gabriele Bergers · VIB-KU Leuven Center for Cancer Biology2 papers (2021–2022)Stefanie Dimmeler · California Institute for Regenerative Medicine2 papers (2021–2022)Pascal Merchiers · Mission Therapeutics (United Kingdom)2 papers (2021–2022)Marie Duhamel · La Ligue Contre le Cancer2 papers (2021–2022)Florian Rambow · Heinrich Heine University Düsseldorf2 papers (2021–2022)
Looking for a research collaborator?
Search millions of scientists by field, institution, impact, and funding status — see their work, find their email, and reach out directly.
Find collaborators in Immunology · Oncology →